標(biāo)題: Titlebook: Angiogenesis and Direct Myocardial Revascularization; Roger J. Laham,Donald S. Baim Book 2005 Humana Press 2005 Chemokine.angiogenesis.car [打印本頁(yè)] 作者: 螺絲刀 時(shí)間: 2025-3-21 17:42
書(shū)目名稱Angiogenesis and Direct Myocardial Revascularization影響因子(影響力)
書(shū)目名稱Angiogenesis and Direct Myocardial Revascularization影響因子(影響力)學(xué)科排名
書(shū)目名稱Angiogenesis and Direct Myocardial Revascularization網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Angiogenesis and Direct Myocardial Revascularization網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Angiogenesis and Direct Myocardial Revascularization被引頻次
書(shū)目名稱Angiogenesis and Direct Myocardial Revascularization被引頻次學(xué)科排名
書(shū)目名稱Angiogenesis and Direct Myocardial Revascularization年度引用
書(shū)目名稱Angiogenesis and Direct Myocardial Revascularization年度引用學(xué)科排名
書(shū)目名稱Angiogenesis and Direct Myocardial Revascularization讀者反饋
書(shū)目名稱Angiogenesis and Direct Myocardial Revascularization讀者反饋學(xué)科排名
作者: magnanimity 時(shí)間: 2025-3-21 21:58
Schirmung mittels Nanomaterialien, (2) protecting extremities from ischemic ulcers and other damage leading to limb loss, (3) providing relief from ischemic symptoms, and/or (4) improving functional capacity. Antiangiogenic agents may prove valuable in slowing or stopping cancers.作者: 圍裙 時(shí)間: 2025-3-22 03:07 作者: 危機(jī) 時(shí)間: 2025-3-22 04:56
Metallgeh?use mit Magnetmaterialienn to promoting blood vessel growth, these angiogenic growth factors have the potential to influence important biological processes such as the response to injury and cell survival. This chapter reviews the use of angiogenic growth factors for therapeutic angiogenesis in peripheral arterial disease.作者: 不朽中國(guó) 時(shí)間: 2025-3-22 08:45
Gene Therapy for Angiogenesis in the Treatment of Cardiovascular and Peripheral Arterial Disease,rdiovascular disease. These medications include platelet inhibitors (aspirin and thienopyridines), angiotensin-converting enzyme inhibitors, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (“statins”).作者: fabricate 時(shí)間: 2025-3-22 13:28 作者: lavish 時(shí)間: 2025-3-22 18:12 作者: Insubordinate 時(shí)間: 2025-3-23 00:52
Imaging Angiogenesis,, (2) protecting extremities from ischemic ulcers and other damage leading to limb loss, (3) providing relief from ischemic symptoms, and/or (4) improving functional capacity. Antiangiogenic agents may prove valuable in slowing or stopping cancers.作者: 繞著哥哥問(wèn) 時(shí)間: 2025-3-23 03:17 作者: Predigest 時(shí)間: 2025-3-23 08:27
2196-8969 elopmental pathways to new treatment strategies, such as therapeutic angiogenesis and myogenesis. The authors take advantage of new biological understanding, novel therapeutic targets, multiple available and well-studied therapeutic strategies, and the necessary imaging techniques to measure outcome作者: Commonplace 時(shí)間: 2025-3-23 10:29 作者: 翻布尋找 時(shí)間: 2025-3-23 15:44
Preclinical Models and Experience to Date,s to illuminate the complexity of angiogenic agents. Therapeutic modalities including autologous stem cell transplantation, targeted protein delivery, prolonged protein half-life, and various combination therapies are only some of the areas that require further investigation.作者: 奇怪 時(shí)間: 2025-3-23 18:10
Book 2005mokines, a better understanding of the effects of aging, endothelial dysfunction, and hypercholesterolemia in response to angiogenic stimuli. Highlights include examination of drug delivery problems, outcomes measure, stem therapy, high-risk interventions, development pathways, and future possibilities.作者: 壓倒 時(shí)間: 2025-3-23 22:18
https://doi.org/10.1007/3-540-28297-1 Furthermore, development of microangiography methods allowed for visualization of the coronary microcirculation in mammals (.,.). The most important finding of these studies was the inhomogeneity of the resistance vessels (.).作者: Antecedent 時(shí)間: 2025-3-24 05:23 作者: orthodox 時(shí)間: 2025-3-24 06:39
The Coronary Microcirculation and Angiogenesis, Furthermore, development of microangiography methods allowed for visualization of the coronary microcirculation in mammals (.,.). The most important finding of these studies was the inhomogeneity of the resistance vessels (.).作者: perpetual 時(shí)間: 2025-3-24 14:39
Transmyocardial Laser Revascularization, sole therapy required advancements in the technology to establish its efficacy. Since then, more than 15,000 patients have been treated with TMR around the world and results from individual institutions, multicenter studies, and prospective randomized control trials have been reported (.–.).作者: effrontery 時(shí)間: 2025-3-24 15:22 作者: Medicare 時(shí)間: 2025-3-24 20:30
https://doi.org/10.1007/3-540-28297-1elopmental processes, such as hematopoiesis and myogenesis, in which several cell- or tissue-specific transcription factors have been identified. Vascular development requires the differentiation of endothelial cells from pluripotent stem cells. Progress in identifying the molecular mechanisms under作者: 微生物 時(shí)間: 2025-3-24 23:28
Numerische Verfahren zur Feldberechnung,there have been great efforts to begin such research in human trials. There is still, however, an ongoing need for continued preclinical investigations to illuminate the complexity of angiogenic agents. Therapeutic modalities including autologous stem cell transplantation, targeted protein delivery,作者: myelography 時(shí)間: 2025-3-25 05:47 作者: Osteoarthritis 時(shí)間: 2025-3-25 10:19
https://doi.org/10.1007/3-540-28297-1 may be limited to incomplete percutaneous coronary intervention (PCI) or surgical procedures (.,.–.). These so-called no-option patients often progress to end-stage ischemic cardiomyopathy with an annual mortality in excess of 30% (.). Treatment options for this group remain limited to multidrug me作者: 昏暗 時(shí)間: 2025-3-25 15:04 作者: 鑲嵌細(xì)工 時(shí)間: 2025-3-25 16:10
https://doi.org/10.1007/978-3-658-10723-9isease (CAD) in the last few decades. As a result of these improvements in cardiovascular care and the aging of the population, anincreasing number of patients have incomplete revascularization or recurrent myocardial ischemia and are suboptimal candidates for surgical (coronary artery bypass grafti作者: inventory 時(shí)間: 2025-3-25 23:14
Schirmd?mpfung eines Drahtgeflechtesent of atherosclerosis. The respective roles of the endothelium, inflammatory mediators, and thrombosis in the pathogenesis of vascular disease are beginning to be better understood. As more is learned about the initiation of atherosclerotic cardiovascular disease, new targets for systemic therapies作者: 傳授知識(shí) 時(shí)間: 2025-3-26 01:47
Metallgeh?use mit Magnetmaterialienalities in angiogenesis are associated with a number of pathological states. Strategies designed to promote angiogenesis to treat disorders of inadequate tissue perfusion, such as occurs in peripheral arterial disease, have led to the area of therapeutic angiogenesis. Angiogenic growth factors of va作者: 短程旅游 時(shí)間: 2025-3-26 06:45
Metallgeh?use mit Magnetmaterialien myocardial infarction, angina pectoris, or both (.). Although recent advances in medical treatment and interventional procedures have reduced the mortality in patients with coronary artery disease (.), the number of patients with refractory myocardial ischemia and congestive heart failure is rapidl作者: 施舍 時(shí)間: 2025-3-26 08:54 作者: overshadow 時(shí)間: 2025-3-26 15:20
Schirmd?mpfung an Schichten für Leitungenlion Americans suffer a myocardial infarction (MI) annually. Of those who survive, 22% of men and 46% of women are disabled with heart failure (.). Although cardiomyocytes of infarcted or failing human hearts have been shown to undergo mitoses (.,.), this regenerative capacity is by far too limited 作者: FAST 時(shí)間: 2025-3-26 17:51 作者: QUAIL 時(shí)間: 2025-3-27 00:43
Angiogenesis and Direct Myocardial Revascularization978-1-59259-934-9Series ISSN 2196-8969 Series E-ISSN 2196-8977 作者: elucidate 時(shí)間: 2025-3-27 01:31
Roger J. Laham,Donald S. BaimIncludes supplementary material: 作者: 抗體 時(shí)間: 2025-3-27 06:00
Contemporary Cardiologyhttp://image.papertrans.cn/a/image/157410.jpg作者: 培養(yǎng) 時(shí)間: 2025-3-27 12:49
https://doi.org/10.1007/978-1-59259-934-9Chemokine; angiogenesis; cardiovascular; circulation; drug; drug delivery; gene therapy; transplantation作者: terazosin 時(shí)間: 2025-3-27 15:50 作者: 審問(wèn),審訊 時(shí)間: 2025-3-27 19:28
2196-8969 in response to angiogenic stimuli. Highlights include examination of drug delivery problems, outcomes measure, stem therapy, high-risk interventions, development pathways, and future possibilities.978-1-61737-393-0978-1-59259-934-9Series ISSN 2196-8969 Series E-ISSN 2196-8977 作者: 使習(xí)慣于 時(shí)間: 2025-3-28 01:50 作者: Substitution 時(shí)間: 2025-3-28 04:26
https://doi.org/10.1007/3-540-28297-1d disruption of additional transcription factors that have been associated with vascular defects led to the elucidation of a role for these factors in vascular development. Angiogenesis, the development of additional blood vessels from a primary vascular network, may recapitulate many of the molecul作者: 臭名昭著 時(shí)間: 2025-3-28 07:22 作者: Collected 時(shí)間: 2025-3-28 10:31 作者: adulterant 時(shí)間: 2025-3-28 15:41 作者: 平淡而無(wú)味 時(shí)間: 2025-3-28 22:40
Schirmd?mpfung an Schichten für Leitungenads to symptoms of heart failure in a significant number of patients. For conventional coronary revascularization to be beneficial, viable myocardium must be present. The prognosis for these patients is poor, with a 1-yr mortality rate of 20% and a 5-yr mortality rate of close to 50% (.).作者: 艦旗 時(shí)間: 2025-3-28 23:06 作者: Ccu106 時(shí)間: 2025-3-29 06:51 作者: Sleep-Paralysis 時(shí)間: 2025-3-29 07:55
Myocardial Angiogenesis,es for CABG or PCI or receive incomplete revascularization with current revascularization strategies (.–.). As a result, many of these patients have residual symptoms and limited quality of life despite maximal medical therapy (frequently described as “refractory angina pectoris”) (.,.). Therefore, 作者: 誰(shuí)在削木頭 時(shí)間: 2025-3-29 13:43
Bone Marrow Cell Transplantation for Myocardial Regeneration and Therapeutic Angiogenesis,n (angiogenesis) and growing new heart muscle fibers (myocardial regeneration) are attractive alternatives. Accumulating evidence suggests that bone marrow cells have the potential of contributing to tissue revascularization and cardiac regeneration after myocardial injury. This chapter summarizes t作者: FRAX-tool 時(shí)間: 2025-3-29 19:11
Transplantation of Embryonic Stem Cells for Myocardial Regeneration and Angiogenesis,en referred to as regenerative or reparative medicine. Stem cell-based cellular cardiomyoplasty (CCM) for cardiomyocyte replacement/regeneration has been evaluated in animal settings (.–.) and clinical trials (.–.). Transplantation of exogenous stem cells could regenerate damaged myocardium and impr作者: Emg827 時(shí)間: 2025-3-29 20:28 作者: 朦朧 時(shí)間: 2025-3-30 01:29
No-Option Patients, the leading cause of morbidity and mortality in the Western Hemisphere. Cardiovascular disease accounted for 38.5% of all deaths or 1 of every 2.6 deaths in the United States in 2001. Cardiovascular disease mortality was about 60% of “total mortality,” i.e., of over 2,400,000 deaths from all causes作者: Hot-Flash 時(shí)間: 2025-3-30 06:22
Transcriptional Regulation of Angiogenesis,elopmental processes, such as hematopoiesis and myogenesis, in which several cell- or tissue-specific transcription factors have been identified. Vascular development requires the differentiation of endothelial cells from pluripotent stem cells. Progress in identifying the molecular mechanisms under作者: 偶像 時(shí)間: 2025-3-30 08:48 作者: 使激動(dòng) 時(shí)間: 2025-3-30 13:26 作者: 反應(yīng) 時(shí)間: 2025-3-30 19:44
